This is a non-core endpoint: only basic statistics are computed.
See these related core endpoints for full statistics:
Injury of nerves at hip and thigh level
ST19_INJURY_NERVES_HIP_THIGH_LEVEL
No definition available.
Endpoint definition
↥Report an error or suggest an improvement for this endpoint codes
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
519972 |
1. Apply sex-specific ruleNone |
519972 |
2. Check conditionsNone |
519972 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters: 2 out of 7 registries used, show all original rules. |
140 |
4. Check minimum number of eventsNone |
140 |
5. Include endpointsNone |
140 |
6. Filter based on genotype QC (FinnGen only) |
137 |
Control definitions (FinnGen only)
- Control exclude
- ST19_INJURI_HIP_THIGH
Extra metadata
- Level in the ICD hierarchy
- 3
- First used in FinnGen datafreeze
- DF4
- Parent code in ICD-10
- S7
- Name in latin
- Laesio nervorum regionis coxae/femoris
Similar endpoints
↥List of similar endpoints to
Injury of nerves at hip and thigh level
based on the number of shared cases.
Similar with more cases:
- Injuries to the hip and thigh
- Injury, poisoning and certain other consequences of external causes
- Any operation in hilmo
- Any event in hilmo or specialist outpatient
- Any prescribed medicine buy
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
This endpoint is excluded from FinRegistry analyses (omitted endpoint).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 137 | 76 | 61 |
| Unadjusted period prevalence (%) | 0.03 | 0.03 | 0.03 |
| Median age at first event (years) | 59.38 | 55.93 | 63.67 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 140
- Matched controls
- 1400
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
S74.0
ICD-10 Finland
Injury of sciatic nerve at hip and thigh level
+∞
45.3
41
*
S74.1
ICD-10 Finland
Injury of femoral nerve at hip and thigh level
+∞
34.9
32
*
S74.9
ICD-10 Finland
Injury of unspecified nerve at hip and thigh level
+∞
29.2
27
*
S74.2
ICD-10 Finland
Injury of cutaneous sensory nerve at hip and thigh level
+∞
24.7
23
*
N03AX16
ATC
[U] pregabalin
5.8
24.3
72
215
X58
ICD-10 Finland
Exposure to other specified factors
6.5
23.2
49
107
N03AX12
ATC
[U] gabapentin; oral
4.8
17.4
54
161
NF1AA
NOMESCO Finland
Hip X-ray examination
6.8
16.8
30
54
NE1AA
NOMESCO Finland
Pelvis X-ray examination
7.2
16.8
28
47
S74.8
ICD-10 Finland
Injury of other nerves at hip and thigh level
+∞
15.9
15
*
W01
ICD-10 Finland
Fall on same level from slipping, tripping and stumbling
4.0
14.8
67
260
N02AE01
ATC
buprenorphine; parenteral, sublingual, transdermal
4.8
13.8
38
101
NA3AA
NOMESCO Finland
Lumbar spine X-ray examination without contrast
5.3
13.4
31
71
T81.4
ICD-10 Finland
Infection following a procedure, not elsewhere classified
5.0
13.2
33
81
NA3BG
NOMESCO Finland
Lumbar spine MRI examination with high intensity magnet
4.9
12.5
32
80
N02AX02
ATC
tramadol; systemic, rectal
3.6
12.4
85
422
Y83
ICD-10 Finland
Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
5.9
11.7
23
45
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
3.3
10.9
71
334
G57.3
ICD-10 Finland
Lesion of lateral popliteal nerve
28.4
10.0
13
5
N06AX16
ATC
venlafaxine; oral
3.7
9.9
38
127
S72.0
ICD-10 Finland
Fracture of neck of femur
107.0
9.5
10
*
WX700
NOMESCO Finland
Respiratory and circulatory monitoring
3.7
9.2
35
116
X59
ICD-10 Finland
Exposure to unspecified factor
3.4
9.2
43
163
ZXD05
NOMESCO Finland
Urgent procedure
3.0
9.2
62
292
B01AB05
ATC
enoxaparin; parenteral
3.0
9.1
65
315
NE1AD
NOMESCO Finland
Pelvis and hip bones CT examination
20.3
9.1
13
7
NG1AA
NOMESCO Finland
Knee X-ray examination without contrast
3.9
8.8
30
92
T84.0
ICD-10 Finland
Mechanical complication of internal joint prosthesis
12.8
8.8
15
13
S76.3
ICD-10 Finland
Injury of muscle and tendon of the posterior muscle group at thigh level
53.4
8.8
10
*
N06AX21
ATC
duloxetine; oral
3.8
8.7
31
98
M79.6
ICD-10 Finland
Pain in limb
2.9
8.7
77
417
R4120
NOMESCO Finland
Occupational therapy
5.0
8.7
20
45
S70.0
ICD-10 Finland
Contusion of hip
21.7
8.6
12
6
M79.2
ICD-10 Finland
Neuralgia and neuritis, unspecified
29.6
8.6
11
*
Y83.8
ICD-10 Finland
Other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
10.5
8.5
16
17
M16.1
ICD-10 Finland
Other primary coxarthrosis
3.8
8.4
29
90
ZXE10
NOMESCO Finland
More than one and less than three hours
2.8
8.3
69
359
Y88.3
ICD-10 Finland
Sequelae of surgical and medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
11.0
8.3
15
15
NE1CG
NOMESCO Finland
Pelvic, hip and femur extensive MRI examination with high intensity magnet
35.6
8.2
10
*
ZXA00
NOMESCO Finland
Right side
2.9
8.1
52
236
M54.4
ICD-10 Finland
Lumbago with sciatica
3.1
7.7
39
154
SPAT1223
SPAT
Implementation of physical therapy rehabilitation plan
2.8
7.6
56
272
T93.4
ICD-10 Finland
Sequelae of injury of nerve of lower limb
84.4
7.5
8
*
S72.3
ICD-10 Finland
Fracture of shaft of femur
+∞
7.3
7
*
N02AA59
ATC
codeine, combinations excl. psycholeptics; systemic
2.6
7.2
79
463
L28
ICPC
Limited function/disability (L)
3.2
7.1
34
129
NFB30
NOMESCO Finland
Primary total prosthetic replacement of hip joint not using cement
4.5
7.1
18
44
NF3AA
NOMESCO Finland
Femur X-ray examination
14.8
7.0
11
8
GD1PA
NOMESCO Finland
X-ray examination of the lungs in one projection
3.7
6.9
24
74
N03AX09
ATC
lamotrigine; oral
6.1
6.9
18
33
M17.1
ICD-10 Finland
Other primary gonarthrosis
2.8
6.7
42
185
ZXD35
NOMESCO Finland
Usual procedure
9.4
6.7
13
15
S18
ICPC
Laceration/cut
2.5
6.6
77
460
Z3226
NOMESCO Finland
Physiotherapist
2.9
6.5
38
161
ZXM10
NOMESCO Finland
Intraoperative use of conventional X-ray imaging
4.2
6.5
18
47
N02BF02
ATC
pregabalin; oral
4.2
6.5
18
47
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
3.3
6.5
27
94
G57.2
ICD-10 Finland
Lesion of femoral nerve
73.0
6.5
7
*
NFJ62
NOMESCO Finland
Internal fixation of fracture of other parts of femur with plate
+∞
6.3
6
*
S73.0
ICD-10 Finland
Dislocation of hip
+∞
6.3
6
*
S72.4
ICD-10 Finland
Fracture of lower end of femur
+∞
6.3
6
*
NE1BG
NOMESCO Finland
Pelvic, hip and femur MRI examination with high intensity magnet
8.3
6.3
13
17
NA3CG
NOMESCO Finland
Lumbar spine extensive MRI examination with high intensity magnet
7.3
6.2
14
21
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
89
528
2.88
8.34
3.4
2.6
—
—
—
0
0
46
241
2.35
5.00
1.8
1.8
0.56
1.33
mg/l
2.88
36
191
48
268
2.20
4.42
3.7
2.4
—
—
—
0
0
78
527
2.08
4.35
11.7
12.2
1.15
1.20
inr
0.28
23
162
11
21
5.59
4.24
1.7
1.7
—
—
—
0
0
39
211
2.18
3.82
5.5
3.1
21.37
106.57
ng/l
1.86
30
160
18
71
2.76
3.45
3.1
4.5
25.35
24.45
mmol/l
0.43
18
71
77
566
1.80
2.93
7.2
6.8
1.22
1.21
mmol/l
0.47
66
481
5
6
8.58
2.77
1.0
1.3
—
—
—
0
0
11
35
3.32
2.71
1.4
2.0
—
—
—
0
0
29
159
2.04
2.70
4.4
6.1
105.03
104.63
mmol/l
0.26
29
159
61
429
1.75
2.62
4.0
3.0
—
—
—
0
0
30
169
1.99
2.59
1.5
1.9
—
—
—
0
0
6
11
5.64
2.57
1.0
1.2
—
—
—
0
0
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
5
7
7.35
2.57
1.0
1.3
—
—
—
0
0
51
344
1.76
2.51
3.5
3.0
0.23
0.48
e6/l
1.12
39
259
57
397
1.74
2.51
2.5
3.1
27.40
33.55
u/l
1.16
57
379
129
1149
2.56
2.44
23.0
14.3
24.23
21.32
mg/l
0.43
111
910
6
12
5.17
2.43
1.0
1.2
—
—
—
0
0
21
108
2.11
2.30
2.0
2.6
0.23
0.22
g/l
0.49
21
99
10
35
3.00
2.26
1.3
2.4
—
—
—
0
0
10
35
3.00
2.26
1.9
1.7
1.25
1.14
g/l
—
10
35
22
119
2.01
2.12
1.5
1.7
—
—
—
0
0
101
844
1.71
2.10
3.9
4.1
14.85
14.83
pmol/l
0.02
92
759
5
10
5.14
2.09
1.0
1.0
—
—
—
0
0
9
34
2.76
1.90
2.0
1.7
0.24
0.21
g/l
—
9
34
23
132
1.89
1.88
4.0
4.7
217.30
256.88
u/l
1.16
23
125
59
444
1.57
1.80
3.8
3.7
18.85
51.65
ng/l
2.31
43
316
43
300
1.63
1.80
5.3
3.9
0.05
0.00
estimate
0.48
19
113
8
30
2.76
1.75
1.1
1.2
—
1.96
—
0
9
7
25
2.89
1.67
1.3
1.2
—
—
—
0
0
21
123
1.83
1.62
1.5
1.8
—
—
—
0
0
7
27
2.67
1.53
1.0
1.3
—
—
—
0
0
7
27
2.67
1.53
1.0
1.3
—
—
—
0
0
7
28
2.58
1.47
1.7
1.5
—
0.12
—
0
6
17
96
1.88
1.47
1.9
2.4
3.56
5.07
ug/l
0.37
17
85
9
41
2.28
1.40
1.4
1.8
—
—
—
0
0
5
17
3.01
1.37
1.4
1.1
—
—
—
0
0
12
62
2.02
1.32
1.3
1.4
—
—
—
0
0
6
24
2.56
1.32
4.7
2.9
64.33
60.37
%
—
6
24
116
1051
1.60
1.29
5.1
4.8
1.78
1.89
mu/l
0.57
107
942
6
25
2.46
1.25
1.2
1.2
—
—
—
0
0
82
696
1.43
1.25
9.8
10.0
4.09
3.98
e9/l
0.13
69
604
18
111
1.71
1.19
1.6
4.1
6.09
5.55
kpa
0.92
18
106
28
194
1.55
1.19
4.0
3.1
3.13
2.68
e6/l
0.17
14
105
41
309
1.46
1.18
2.5
3.0
333.86
7237.62
umol/l
1.51
35
265
120
1103
1.62
1.17
18.5
13.6
82.63
81.28
ml/min/173m2
0.30
105
905
98
868
1.43
1.12
5.5
4.2
14.35
11.50
mm/h
1.01
92
791
23
156
1.57
1.07
5.1
5.8
1.07
1.07
mmol/l
0.00
18
139
14
83
1.76
1.06
4.9
6.2
0.59
0.66
%
0.24
14
83
7
34
2.11
1.04
1.1
2.1
—
—
—
0
0
54
439
1.37
1.00
4.6
3.9
—
—
—
0
0
19
125
1.60
1.00
4.1
3.7
—
—
—
0
0
9
50
1.85
0.99
4.1
1.7
—
—
—
0
0
15
93
1.69
0.98
1.6
3.1
4.63
4.42
kpa
0.23
15
87
7
37
1.94
0.95
1.7
1.5
—
—
—
0
0
28
207
1.44
0.88
2.7
2.9
1.67
0.84
e6/l
1.03
15
117
43
344
1.36
0.87
2.4
2.7
631.23
1193.21
ng/l
1.28
38
279
17
114
1.56
0.84
2.8
2.0
333.06
356.81
nmol/l
0.18
17
106
65
559
1.30
0.79
4.5
3.8
0.00
0.01
estimate
0.50
19
122
66
569
1.30
0.79
4.5
3.7
0.00
0.00
estimate
-0.00
19
110
13
83
1.62
0.78
5.2
6.2
1.35
1.27
%
0.12
13
83
9
56
1.65
0.74
1.4
1.7
—
—
—
0
0
34
272
1.33
0.68
1.5
1.3
1.67
1.42
u/ml
—
9
75
24
182
1.38
0.67
1.2
1.3
36.05
12.30
u/ml
—
8
74
14
95
1.53
0.67
6.9
3.1
55.00
65.83
ml/min/173m2
—
6
42
64
561
1.26
0.64
5.5
5.2
0.00
0.00
estimate
-0.00
19
118
13
88
1.53
0.63
1.5
1.6
—
—
—
0
0
8
52
1.57
0.60
1.6
2.0
—
—
—
0
0
26
204
1.34
0.60
1.4
1.3
46.00
37.28
iu/ml
—
7
71
6
36
1.70
0.57
2.2
1.3
—
—
—
0
0
6
40
1.52
0.52
1.0
1.2
—
—
—
0
0
6
40
1.52
0.52
5.8
1.9
0.73
0.00
g/l
—
6
40
17
130
1.35
0.46
1.2
1.9
1.37
1.47
%
0.34
17
110
131
1271
1.48
0.45
31.4
21.0
259.25
250.49
e9/l
0.70
131
1239
131
1271
1.48
0.45
31.6
21.1
132.59
135.83
g/l
1.53
131
1250
131
1270
1.49
0.45
31.6
21.0
39.07
40.40
%
1.30
125
1202
0
17
0.00
0.41
0.0
1.1
—
—
—
0
0
9
67
1.37
0.39
3.0
3.5
4.59
4.42
pmol/l
—
9
59
5
36
1.40
0.38
2.6
2.0
—
—
—
0
0
10
73
1.40
0.35
1.1
1.3
—
—
—
0
0
50
450
1.17
0.35
2.5
2.0
89.64
95.20
pmol/l
0.40
29
225
6
45
1.35
0.34
1.5
1.9
—
—
—
0
0
7
56
1.26
0.30
1.0
1.2
—
—
—
0
0
7
56
1.26
0.30
1.0
1.2
—
—
—
0
0
32
283
1.17
0.28
3.2
5.0
24.76
22.47
%
0.37
16
155
65
694
0.88
0.27
3.4
3.1
—
—
—
0
0
5
37
1.36
0.24
1.6
2.5
—
—
—
0
0
5
39
1.29
0.23
6.2
1.9
0.00
0.00
g/l
—
5
39
5
39
1.29
0.23
6.2
1.9
0.00
0.00
g/l
—
5
39
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
0
10
0.00
0.21
0.0
1.4
—
128.97
—
0
10
0
10
0.00
0.21
0.0
1.2
—
—
—
0
0
0
10
0.00
0.21
0.0
1.4
—
—
—
0
0
0
12
0.00
0.21
0.0
1.0
—
—
—
0
0
0
14
0.00
0.20
0.0
4.1
—
33.19
—
0
14
38
357
1.09
0.13
3.7
5.3
1.83
2.56
ug/l
0.87
33
311
115
1129
1.10
0.12
4.3
4.6
5.86
5.97
mmol/l
0.61
109
1028
47
448
1.07
0.11
3.2
2.4
75.80
77.74
nmol/l
0.17
41
398
30
320
0.92
0.11
1.5
1.8
1.65
1.38
mmol/l
0.49
24
276
18
165
1.10
0.09
1.4
1.4
—
—
—
0
0
111
1096
1.06
0.06
4.2
4.1
1.41
1.29
mmol/l
0.85
105
993
15
140
1.08
0.04
4.0
7.7
—
—
—
0
0
10
108
0.92
0.03
2.0
1.9
—
—
—
0
0
113
1137
0.97
0.01
4.7
4.6
4.76
4.64
mmol/l
0.53
108
1045
79
783
1.02
0.01
3.9
3.3
45.12
50.35
u/l
0.41
73
732
21
206
1.02
0.00
1.9
1.5
—
—
—
0
0
113
1133
0.99
0.00
4.6
4.5
1.44
1.47
mmol/l
0.30
106
1034
36
358
1.01
0.00
5.3
3.9
13.09
8.02
mg/mmol
0.32
21
228
117
1165
1.03
0.00
5.1
5.1
2.85
2.74
mmol/l
0.55
110
1063
21
215
0.97
0.00
2.7
3.3
1.34
0.84
ug/l
0.40
14
150
8
87
0.91
0.00
1.4
1.7
—
—
—
0
0
0
9
0.00
-0.00
0.0
2.2
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
7
0.00
-0.00
0.0
2.4
—
—
—
0
0
9
95
0.94
-0.00
2.2
1.7
—
—
—
0
0
0
9
0.00
-0.00
0.0
2.2
—
—
—
0
0
0
7
0.00
-0.00
0.0
2.4
—
—
—
0
0
6
63
0.95
-0.00
1.0
1.0
—
—
—
0
0
0
7
0.00
-0.00
0.0
2.4
—
—
—
0
0
0
7
0.00
-0.00
0.0
2.6
—
55.00
—
0
7
0
5
0.00
-0.00
0.0
1.2
—
0.34
—
0
5
0
7
0.00
-0.00
0.0
3.0
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
10.39
—
0
5
0
8
0.00
-0.00
0.0
4.6
—
—
—
0
0
0
7
0.00
-0.00
0.0
3.0
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.5
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.9
—
13.69
—
0
7
0
5
0.00
-0.00
0.0
6.6
—
221.60
—
0
5
0
7
0.00
-0.00
0.0
4.4
—
58.43
—
0
7
0
9
0.00
-0.00
0.0
1.6
—
28.21
—
0
9
Mortality – FinRegistry
↥This endpoint is excluded from FinRegistry analyses (omitted endpoint).
Relationships between endpoints
↥Index endpoint: ST19_INJURY_NERVES_HIP_THIGH_LEVEL – Injury of nerves at hip and thigh level
GWS hits: -
This endpoint is excluded from FinRegistry analyses (omitted endpoint).